Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment

Jennifer R. Havens, Sharon L. Walsh, Philip (Todd) Korthuis, David A. Fiellin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalCurrent HIV/AIDS Reports
DOIs
StateAccepted/In press - Jun 9 2018

Fingerprint

Hepatitis C
Opioid Analgesics
HIV
Therapeutics
Buprenorphine
Methadone
Heroin
Fentanyl
Prescriptions
Inpatients
Primary Health Care
Epidemiology

Keywords

  • Hepatitis C
  • HIV
  • Opioid treatment
  • Opioid treatment programs

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Implementing Treatment of Opioid-Use Disorder in Rural Settings : a Focus on HIV and Hepatitis C Prevention and Treatment. / Havens, Jennifer R.; Walsh, Sharon L.; Korthuis, Philip (Todd); Fiellin, David A.

In: Current HIV/AIDS Reports, 09.06.2018, p. 1-9.

Research output: Contribution to journalArticle

@article{5e0dc694f9d74ed88cc6664274932e0c,
title = "Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment",
abstract = "Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18{\%} of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3{\%} of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.",
keywords = "Hepatitis C, HIV, Opioid treatment, Opioid treatment programs",
author = "Havens, {Jennifer R.} and Walsh, {Sharon L.} and Korthuis, {Philip (Todd)} and Fiellin, {David A.}",
year = "2018",
month = "6",
day = "9",
doi = "10.1007/s11904-018-0402-3",
language = "English (US)",
pages = "1--9",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Implementing Treatment of Opioid-Use Disorder in Rural Settings

T2 - a Focus on HIV and Hepatitis C Prevention and Treatment

AU - Havens, Jennifer R.

AU - Walsh, Sharon L.

AU - Korthuis, Philip (Todd)

AU - Fiellin, David A.

PY - 2018/6/9

Y1 - 2018/6/9

N2 - Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

AB - Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

KW - Hepatitis C

KW - HIV

KW - Opioid treatment

KW - Opioid treatment programs

UR - http://www.scopus.com/inward/record.url?scp=85048266359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048266359&partnerID=8YFLogxK

U2 - 10.1007/s11904-018-0402-3

DO - 10.1007/s11904-018-0402-3

M3 - Article

C2 - 29948609

AN - SCOPUS:85048266359

SP - 1

EP - 9

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

ER -